Lassa Virus Infection
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
United TherapeuticsARN-75039 oral capsules
Harmony BiosciencesMV-LASV
Clinical Trials (2)
Total enrollment: 94 patients across 2 trials
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects
Start: Jan 2023Est. completion: Mar 202594 patients
Phase 1Completed
A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)
Start: Sep 2019Est. completion: Jan 2021
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space